COVID is a disease caused by the SARS-CoV-2 virus. It causes respiratory symptoms and a wide range of sequelae mainly affecting the lungs.
Stem cell treatment for COVID-19 has shown excellent results in regulating the inflammatory response to combat lung inflammation, fibrosis, and possible sequelae of the disease.
At Stem Life Clinic, we have a protocol for the treatment of COVID-19 with the application of mesenchymal stem cells to help patients affected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its sequelae.
Stem Life Clinic’s COVID-19 stem cell treatment is performed at our facility, with highly trained medical staff to ensure successful and safe infiltration.
Severe acute respiratory syndrome or COVID-19 is a highly contagious inflammatory disease that causes serious complications that can lead to death in those affected.
Currently, treatment options for COVID-19 focus on reducing symptoms, but they do not prevent the complications or damage that the disease can cause in the organs.
Mesenchymal stem cells have regenerative, anti-inflammatory, and immunomodulatory potential, mediating the inflammatory response, immune response, and cell regeneration to prevent, control, and/or stop complications and respiratory failure associated with COVID-19.
Patients with severe cases of COVID-19, who have suffered complications from the disease or who suffer from sequelae such as pulmonary fibrosis, shortness of breath, joint pain, sleeping problems, etc, have benefited from stem cell treatment. Schedule your appointment at the Stem Life Clinic to find out if you are a candidate for treatment.
Mesenchymal stem cells can secrete factors that modulate the lung microenvironment, subdue overactivation of the immune system, enhance tissue repair, invigorate alveolar epithelial cells, and inhibit fibrosis, resulting in massive improvement in lung functions. Mesenchymal stem cells can regenerate other organs damaged because of COVID-19 infection.